Document Detail

Treatment of acute hepatitis C in HIV infection.
MedLine Citation:
PMID:  19861339     Owner:  NLM     Status:  MEDLINE    
Within Europe and recently in the USA and Australia an ongoing epidemic of acute hepatitis C virus (HCV) infections among HIV-positive individuals, mainly men who have sex with men, has been observed. Other concomitant sexually transmitted diseases and sexual practices with a high risk of mucosal trauma and damage have been established as risk factors for sexual transmission. In HIV-positive patients the diagnosis of acute HCV infection may be obscured by delayed anti-HCV antibody seroconversion, and HCV RNA testing may be warranted. It is estimated that up to 85% of HIV-positive patients take a chronic course after acute HCV infection, and early treatment of acute HCV infection within 12 weeks after the presumed date of infection is recommended unless spontaneous clearance of HCV has occurred. A watch and wait strategy for 4-8 weeks after the date of diagnosis with 4 weekly HCV RNA controls may help to distinguish patients who will spontaneously clear acute HCV infection from those who will not. Treatment of acute HCV infection with interferon-based therapy has been shown to be highly efficacious, with sustained virological response rates in between 60% and 70% of HIV-positive individuals. Though data are sparse, controlling treatment response at weeks 4 and 12 may further help to individualize therapy, and patients who have not reached a negative HCV RNA by week 12 may benefit from prolonged treatment beyond 24 weeks.
Martin Vogel; J?rgen K Rockstroh
Related Documents :
15910559 - Systemic autoimmune diseases co-existing with chronic hepatitis c virus infection (the ...
15955219 - Outbreak of hepatitis c virus infection in an outpatient clinic.
12600649 - Epidemiology of hepatitis c virus infection in australia.
24032639 - Hepatitis b virus reactivation after ustekinumab treatment.
16122679 - Global epidemiology of hepatitis c virus infection.
11319519 - Focal segmental glomerulosclerosis and hepatitis c virus: a case report.
12220759 - Human immunodeficiency virus counseling and testing practices among north carolina prov...
23922559 - Lower intrafamilial transmission rate of hepatitis b in patients with hepatitis d coinf...
23719859 - Bone mass, body composition and vitamin d status of arv-naïve, urban, black south afric...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of antimicrobial chemotherapy     Volume:  65     ISSN:  1460-2091     ISO Abbreviation:  J. Antimicrob. Chemother.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-12-16     Completed Date:  2010-02-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513617     Medline TA:  J Antimicrob Chemother     Country:  England    
Other Details:
Languages:  eng     Pagination:  4-9     Citation Subset:  IM    
Department of Internal Medicine I, Bonn University, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antiviral Agents / therapeutic use
Australia / epidemiology
Case Management
Europe / epidemiology
HIV Infections / complications*
Hepatitis C / diagnosis*,  drug therapy*,  epidemiology
Interferons / therapeutic use
United States / epidemiology
Reg. No./Substance:
0/Antiviral Agents; 9008-11-1/Interferons

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucel...
Next Document:  Determinants of mental health stigma among pharmacy students in Australia, Belgium, Estonia, Finland...